We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

112 hedge funds and large institutions have $403M invested in BioDelivery Sciences International, Inc. in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

566% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $1.96M

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

38% more capital invested

Capital invested by funds: $293M → $403M (+$110M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

17% more funds holding

Funds holding: 96112 (+16)

Holders
112
Holders Change
+16
Holders Change %
+16.67%
% of All Funds
3.22%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
25
Increased
44
Reduced
33
Closed
9
Calls
$13.1M
Puts
$1.96M
Net Calls
+$11.1M
Net Calls Change
+$14.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$61.8M -$4.4M -463,800 -8%
BC
2
Broadfin Capital
New York
$40.7M -$948K -100,000 -3%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$32.4M -$3.44M -362,600 -12%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$27.2M -$4.74M -500,000 -18%
ORI
5
Oak Ridge Investments
Illinois
$16.7M +$13.1M +1,386,227 New
DM
6
Deerfield Management
New York
$16M -$25.2M -2,658,460 -67%
BIT
7
BlackRock Institutional Trust
California
$15.2M -$197K -20,828 -2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$14.2M +$1.02M +107,971 +10%
BFA
9
BlackRock Fund Advisors
California
$12.5M -$70.2K -7,403 -0.7%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$10.2M +$5.29M +557,451 +196%
FCMI
11
Foresite Capital Management I
California
$8.45M
PA
12
Perceptive Advisors
New York
$8.45M +$4.84M +510,000 +268%
TI
13
Turner Investments
Pennsylvania
$7.51M +$813K +85,780 +16%
State Street
14
State Street
Massachusetts
$6.75M +$859K +90,561 +19%
GIM
15
Granahan Investment Management
Massachusetts
$6.45M -$911K -96,140 -15%
TCM
16
Timpani Capital Management
Wisconsin
$6.3M +$808K +85,224 +20%
TM
17
Tiger Management
New York
$6.17M
TCM
18
Tekla Capital Management
Massachusetts
$6.05M -$1.72M -181,707 -27%
Millennium Management
19
Millennium Management
New York
$5.1M +$2.49M +262,564 +164%
BBA
20
Baker Bros. Advisors
New York
$5.08M
Northern Trust
21
Northern Trust
Illinois
$5.04M +$24K +2,536 +0.6%
TAM
22
THB Asset Management
Connecticut
$4.99M -$4.09M -431,445 -51%
B
23
Bailard
California
$4.8M +$527K +55,600 +16%
SC
24
Sophrosyne Capital
New York
$4.77M -$1.16M -122,386 -24%
Wellington Management Group
25
Wellington Management Group
Massachusetts
$4.59M +$1.76M +185,866 +96%

BDSI Hedge Fund Activity: Q2 2014 in Review

112 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2014, worth a combined $403M — up 38% from $293M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BDSI positions and 9 closed out — a net gain of 16 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Oak Ridge Investments, opening a new position worth an estimated $13.1M. The largest seller was Deerfield Management, cutting an estimated $25.2M.

  • 112 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2014, up from 96 in Q1 2014.
  • Funds reported $403M of BioDelivery Sciences International, Inc. stock for Q2 2014, up 38% quarter-over-quarter.
  • 25 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2014 and 9 closed out, a net change of +16 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2014 was Oak Ridge Investments, an estimated $13.1M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2014 was Deerfield Management, an estimated $25.2M sold.

Based on aggregated 13F filings for Q2 2014.